Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Comera Life Sciences Holdings, Inc. | Director | Common Stock | 20.8K | $1.47K | $0.07 | Nov 15, 2023 | Direct |
Brooklyn ImmunoTherapeutics, Inc. | Director | Stock Option (right to buy) | 166K | Aug 1, 2022 | Direct | ||
Comera Life Sciences Holdings, Inc. | Director | Stock Option (Right to Purchase) | 75.4K | Nov 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CMRA | Comera Life Sciences Holdings, Inc. | Nov 15, 2023 | 1 | $0 | 4 | Nov 17, 2023 | Director |
CMRA | Comera Life Sciences Holdings, Inc. | Nov 9, 2023 | 1 | $0 | 4 | Nov 14, 2023 | Director |
CMRA | Comera Life Sciences Holdings, Inc. | Aug 31, 2023 | 1 | $0 | 4 | Sep 1, 2023 | Director |
CMRA | Comera Life Sciences Holdings, Inc. | Aug 11, 2023 | 1 | $0 | 4 | Aug 15, 2023 | Director |
CMRA | Comera Life Sciences Holdings, Inc. | May 12, 2023 | 1 | $0 | 4 | May 16, 2023 | Director |
CMRA | Comera Life Sciences Holdings, Inc. | Feb 14, 2023 | 1 | $0 | 4 | Feb 16, 2023 | Director |
CMRA | Comera Life Sciences Holdings, Inc. | Aug 9, 2022 | 1 | $0 | 4 | Aug 11, 2022 | Director |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | Aug 1, 2022 | 2 | $0 | 4 | Aug 3, 2022 | Director |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | Jun 5, 2022 | 0 | $0 | 3 | Jun 7, 2022 | Director |
CMRA | Comera Life Sciences Holdings, Inc. | May 19, 2022 | 0 | $0 | 3 | May 20, 2022 | Director |